Fate Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Revenue	63.53	96.3	55.85	31.43	10.68	4.74	4.11	4.4	2.43	0	Upgrade
Revenue Growth (YoY)	-34.03%	72.44%	77.66%	194.33%	125.32%	15.44%	-6.72%	81.08%	-	-	Upgrade
Gross Profit	63.53	96.3	55.85	31.43	10.68	4.74	4.11	4.4	2.43	0	Upgrade
Selling, General & Admin	81.45	84.23	57.32	33.9	23.64	15.81	11.87	9.91	10.35	8.47	Upgrade
Research & Development	172.6	320.45	215.52	125.62	87.77	56.02	34.36	26.45	19.86	16.44	Upgrade
Operating Expenses	254.04	404.69	272.84	159.52	111.41	71.83	46.23	36.37	30.21	24.9	Upgrade
Operating Income	-190.51	-308.39	-216.99	-128.09	-100.73	-67.09	-42.13	-31.96	-27.78	-24.9	Upgrade
Interest Expense / Income	0	0	0	0	1.75	1.7	1.27	1.64	2.22	0.55	Upgrade
Other Expense / Income	-29.58	-26.67	-4.84	45.3	-4.33	-2.19	-0.44	-0.14	-0.01	0.43	Upgrade
Pretax Income	-160.93	-281.72	-212.15	-173.39	-98.15	-66.6	-42.95	-33.46	-29.99	-25.88	Upgrade
Net Income	-160.93	-281.72	-212.15	-173.39	-98.15	-66.6	-42.95	-33.46	-29.99	-25.88	Upgrade
Shares Outstanding (Basic)	98	97	95	82	68	56	42	32	25	20	Upgrade
Shares Outstanding (Diluted)	98	97	95	82	68	56	42	32	25	20	Upgrade
Shares Change	1.64%	2.19%	15.01%	20.82%	21.35%	33.86%	32.21%	24.60%	24.61%	246.87%	Upgrade
EPS (Basic)	-1.64	-2.91	-2.24	-2.10	-1.44	-1.19	-1.02	-1.05	-1.18	-1.27	Upgrade
EPS (Diluted)	-1.64	-2.91	-2.24	-2.10	-1.44	-1.19	-1.02	-1.05	-1.18	-1.27	Upgrade
Free Cash Flow	-138.42	-283.77	-213.57	-44.16	-90.57	-40.95	-38.54	-30.26	-19.9	-23.3	Upgrade
Free Cash Flow Per Share	-1.41	-2.93	-2.25	-0.54	-1.33	-0.73	-0.92	-0.95	-0.78	-1.14	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	-	Upgrade
Operating Margin	-299.86%	-320.23%	-388.56%	-407.47%	-943.14%	-1415.44%	-1025.94%	-726.10%	-1142.82%	-	Upgrade
Profit Margin	-253.30%	-292.55%	-379.89%	-551.59%	-919.00%	-1405.02%	-1046.08%	-760.15%	-1233.73%	-	Upgrade
Free Cash Flow Margin	-217.86%	-294.68%	-382.43%	-140.49%	-848.03%	-863.99%	-938.68%	-687.46%	-818.39%	-	Upgrade
EBITDA	-142.65	-267.96	-206.3	-170.3	-94.2	-63.7	-40.71	-30.94	-27.09	-24.84	Upgrade
EBITDA Margin	-224.52%	-278.26%	-369.41%	-541.77%	-882.06%	-1343.84%	-991.55%	-702.95%	-1114.15%	-	Upgrade
Depreciation & Amortization	18.28	13.76	5.85	3.09	2.19	1.2	0.97	0.88	0.69	0.5	Upgrade
EBIT	-160.93	-281.72	-212.15	-173.39	-96.4	-64.9	-41.68	-31.83	-27.77	-25.33	Upgrade
EBIT Margin	-253.30%	-292.55%	-379.89%	-551.59%	-902.59%	-1369.24%	-1015.20%	-722.97%	-1142.41%	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).